Profile data is unavailable for this security.
About the company
Corline Biomedical AB is a Sweden-based biotechnology company. It develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.
- Revenue in SEK (TTM)7.56m
- Net income in SEK-23.85m
- Incorporated1991
- Employees13.00
- LocationCorline Biomedical ABLefflersgatan 5UPPSALA 75450SwedenSWE
- Phone+46 1 871346946
- Fax+46 18713091
- Websitehttps://www.corline.se/home
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arctic Bioscience AS | 41.30m | -40.73m | 85.58m | 22.00 | -- | 0.4649 | -- | 2.07 | -1.67 | -1.67 | 1.69 | 7.27 | 0.156 | 0.9957 | 4.02 | 1,998,510.00 | -15.39 | -15.49 | -18.84 | -17.83 | 28.45 | 28.52 | -98.62 | -125.49 | 0.3389 | -9.68 | 0.2202 | -- | 28.84 | 7.68 | -5.31 | -- | -- | -- |
| StenoCare A/S | 8.04m | -34.84m | 89.22m | 8.00 | -- | 25.37 | -- | 11.09 | -0.8176 | -0.8176 | 0.1569 | 0.0572 | 0.324 | -- | 3.80 | 709,217.50 | -140.37 | -45.69 | -201.07 | -59.64 | -- | -- | -433.19 | -739.04 | 1.32 | -6.51 | 0.526 | -- | -40.60 | -14.70 | -96.30 | -- | -64.95 | -- |
| Vivesto AB | 0.00 | -35.72m | 101.37m | 4.00 | -- | 0.3795 | -- | -- | -0.0664 | -0.0664 | 0.00 | 0.2483 | 0.00 | -- | -- | 0.00 | -21.35 | -- | -23.62 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 69.12 | -- | -- | -- |
| IRLAB Therapeutics AB | 85.56m | -91.91m | 155.80m | 31.00 | -- | 2.88 | -- | 1.82 | -1.56 | -1.56 | 1.40 | 0.6382 | 0.5172 | -- | 8.93 | 3,168,815.00 | -55.56 | -27.34 | -149.51 | -32.01 | -35.80 | -45.70 | -107.43 | -112.19 | -- | -4.29 | 0.3548 | -- | 1,566.57 | 415.48 | 53.26 | -- | 7.75 | -- |
| Isofol Medical AB (publ) | 0.00 | -54.49m | 169.51m | 6.00 | -- | 1.41 | -- | -- | -0.2698 | -0.2698 | 0.00 | 0.4291 | 0.00 | -- | -- | 0.00 | -43.21 | -61.58 | -51.19 | -82.71 | -- | -740.36 | -- | -861.94 | -- | -- | 0.00 | -- | -100.00 | -- | -17.31 | -- | -- | -- |
| Magle Chemoswed Holding AB | 292.44m | -26.60m | 225.08m | 144.00 | -- | 0.4233 | 8.12 | 0.7697 | -1.29 | -1.29 | 14.56 | 25.75 | 0.3085 | -0.0596 | 8.14 | 1,989,374.00 | -2.81 | 2.43 | -3.45 | 3.45 | 102.66 | 88.63 | -9.09 | 4.76 | 0.8205 | -0.1043 | 0.3887 | 0.00 | 38.49 | 13.10 | -1.91 | 74.06 | -21.72 | -- |
| Elicera Therapeutics AB | 13.70m | -13.04m | 228.12m | 2.00 | -- | 7.44 | -- | 16.66 | -0.3434 | -0.3434 | 0.3712 | 0.6314 | 0.4004 | -- | 9.61 | 6,848,050.00 | -38.14 | -42.99 | -48.58 | -55.48 | -- | -- | -95.24 | -345.69 | -- | -- | 0.00 | -- | -36.52 | -- | 1.75 | -- | -- | -- |
| Lipum AB (publ) | 0.00 | -76.37m | 290.61m | 6.00 | -- | -- | -- | -- | -3.60 | -3.60 | 0.00 | -1.33 | 0.00 | -- | -- | 0.00 | -179.79 | -146.87 | -660.20 | -220.28 | -- | -- | -- | -1,379,275.00 | -- | -39.82 | 3.77 | -- | -- | -- | -49.32 | -- | -- | -- |
| Biohit Oyj | 166.26m | 28.59m | 377.93m | 46.00 | 16.43 | 2.98 | 10.50 | 2.27 | 0.1778 | 0.1778 | 1.03 | 0.9804 | 0.8895 | 5.36 | 4.61 | 341,304.30 | 15.86 | 9.67 | 19.52 | 12.32 | 68.79 | 65.69 | 17.83 | 9.82 | 2.31 | -- | 0.097 | 0.00 | 9.92 | 17.12 | 5.14 | -- | 109.13 | -- |
| Corline Biomedical AB | 7.56m | -23.85m | 412.38m | 13.00 | -- | 5.11 | -- | 54.55 | -1.02 | -1.02 | 0.3142 | 3.15 | 0.0862 | -- | 10.59 | 581,461.60 | -27.20 | -8.36 | -29.49 | -9.10 | 82.54 | 121.50 | -315.49 | -53.37 | -- | -1,153.67 | 0.00 | -- | -60.95 | 55.82 | -1,182.15 | -- | 9.13 | -- |
| Enzymatica AB (publ) | 52.73m | -54.14m | 417.50m | 21.00 | -- | 3.08 | -- | 7.92 | -0.2257 | -0.2257 | 0.2198 | 0.559 | 0.292 | 1.26 | 4.54 | 2,510,953.00 | -29.98 | -29.10 | -31.26 | -34.48 | 63.76 | 63.82 | -102.68 | -73.32 | -- | -- | 0.0095 | -- | -10.47 | -5.76 | -6.94 | -- | -14.62 | -- |
| Moberg Pharma AB (publ) | 12.50m | -257.79m | 446.69m | 6.00 | -- | 0.6367 | -- | 35.74 | -5.52 | -5.52 | 0.2672 | 14.40 | 0.0153 | 0.9991 | 1.87 | 1,388,556.00 | -31.46 | -- | -32.04 | -- | 52.35 | -- | -2,062.80 | -- | 15.81 | -- | 0.0044 | -- | -- | -- | -1,109.46 | -- | -- | -- |
| Navamedic ASA | 506.69m | -37.04m | 493.33m | 45.00 | -- | 2.50 | -- | 0.9736 | -2.21 | -2.21 | 27.98 | 8.74 | 0.883 | 3.27 | 6.40 | 12,843,290.00 | -6.45 | -0.3087 | -8.75 | -0.4895 | 37.32 | 39.37 | -7.31 | -0.2916 | 0.7697 | 0.192 | 0.5978 | -- | 3.80 | 23.00 | 59.92 | -- | 35.76 | -- |
Data as of Feb 16 2026. Currency figures normalised to Corline Biomedical AB's reporting currency: Swedish Krona SEK
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Atle Fund Management ABas of 31 Dec 2024 | 0.00 | 0.00% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
